author-photo

Sjoerd H. Hofma

Erasmus University Rotterdam
Medisch Centrum Leeuwarden

119

Papers

5761

Citations

Citation Trend

Filter By

Papers (88) Sort By

Journal Conference Others

Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry.

2021 BMC Cardiovascular Disorders
Show All
- Source
- Cite
- Save
Citations (1)
The Influence of Implantation Techniques on Lesion-Oriented Outcomes in Absorb BVS and Xience EES Lesions Treated in Routine Clinical Practice at Complete Three-Year Follow-Up - AIDA Trial QCA Substudy

2021 Cardiovascular Revascularization Medicine
Show All
- Source
- Cite
- Save
Citations (0)
TCT-316 Impact of Geographic Variation on the Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent: Results From the PIONEER III Clinical Trial in North America, Europe, and Japan

2021 Journal of the American College of Cardiology
Show All
- Source
- Cite
- Save
Citations (0)
SIMILAR OUTCOMES WITH THE SUPREME™BIODEGRADABLE DRUG COATED CORONARY STENT SYSTEM IN ACUTE CORONARY SYNDROME AND CHRONIC CORONARY SYNDROMES: RESULTS OF THE PROSPECTIVE MULTICENTER RANDOMIZED CONTROLLED PIONEER III TRIAL

2021 Journal of the American College of Cardiology
Show All
- Source
- Cite
- Save
Citations (0)
Novel SupremeTM DES with Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation after DES implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial.

2021 Circulation
Show All
- Source
- Cite
- Save
Citations (3)
Long-Term Clinical Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: Final 5-Year Results of the AIDA Randomized Clinical Trial.

2021 Eurointervention
Show All
- Source
- Cite
- Save
Citations (0)
Four-Year Follow-Up of Absorb BVS Compared to Xience EES in Daily Clinical Practice Shows Continued Accrual of Events

2021 Cardiovascular Revascularization Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex: Two-Year Outcomes of the TALENT Trial.

2021 Circulation-cardiovascular Interventions
Show All
- Source
- Cite
- Save
Citations (3)
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients.

2021 International Journal of Cardiology
Show All
- Source
- Cite
- Save
Citations (1)
A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial

2020 European Heart Journal
Show All
- Source
- Cite
- Save
Citations (2)